Clinical Trial Update: Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.

View source ↗

Summary

Completed clinical trial evaluating empirical proton pump inhibitor treatment for outpatients with typical gastroesophageal reflux disease symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Proton pump inhibitor (PPI) (proton-pump inhibitor)

Snippet

Sponsor: AstraZeneca | Conditions: Patients With Typical Symptoms of GERD (GERD Q >= 8) | Status: COMPLETED